Our findings that an increased RANKL/OPG ratio > 12 months prior to breast cancer development is consistent with findings from meta-analysis by Key et al. that showed that sex steroid hormone levels well in advance of breast cancer diagnosis are more significantly associated with breast cancer risk compared with hormone levels analyzed closer to diagnosis [30]. This evidence concerns the gene TNFSF11 and breast cancer.